BioVaxys Technology Statistics

Total Valuation

BioVaxys Technology has a market cap or net worth of CAD 18.94 million. The enterprise value is 18.53 million.

Market Cap	18.94M
Enterprise Value	18.53M

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

BioVaxys Technology has 291.37 million shares outstanding. The number of shares has increased by 37.87% in one year.

Current Share Class	n/a
Shares Outstanding	291.37M
Shares Change (YoY)	+37.87%
Shares Change (QoQ)	+5.68%
Owned by Insiders (%)	13.85%
Owned by Institutions (%)	n/a
Float	220.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.11
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.39

Current Ratio	0.39
Quick Ratio	0.33
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-80.36%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +180.00% in the last 52 weeks. The beta is -0.05, so BioVaxys Technology's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+180.00%
50-Day Moving Average	0.06
200-Day Moving Average	0.07
Relative Strength Index (RSI)	48.96
Average Volume (20 Days)	360,921

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.46M
Pretax Income	-3.63M
Net Income	-3.63M
EBITDA	n/a
EBIT	-2.46M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 490,845 in cash and 81,206 in debt, giving a net cash position of 409,639 or 0.00 per share.

Cash & Cash Equivalents	490,845
Total Debt	81,206
Net Cash	409,639
Net Cash Per Share	0.00
Equity (Book Value)	-249,195
Book Value Per Share	-0.00
Working Capital	-1.63M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-848,768
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioVaxys Technology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.87%
Shareholder Yield	-37.87%
Earnings Yield	-32.57%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a